Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Anthera Pharmaceuticals Inc    

ANTHERA PHARMACEUTICALS INC

 SummaryNewsCalendarCompany 
Company
Anthera Pharmaceuticals, Inc. (Anthera) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases. The Company has two Phase III product candidates,... 
More about the company
Latest news on ANTHERA PHARMACEUTICALS IN
2017ANTHERA PHARMACEUTICALS INC : REVERSE SPLIT: 1 of 8
FA
2017Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock
GL
2017Anthera Announces Completion of Dosing in the Phase 2 BRIGHT-SC Study of Blis..
GL
2017DEADLINE ALERT : Brower Piven Reminds Investors Of The Upcoming Deadline In Clas..
BU
2017Anthera Announces Positive Results from the Extension Period of the SOLUTION ..
GL
2017ANTH The Law Offices of Vincent Wong Reminds Investors of a Class Action Invo..
BU
2017Anthera Pharmaceuticals Announces Pricing of $15.0 Million Public Offering of..
GL
2017Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock an..
GL
2017Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 Fr..
BU
2017ANTHERA PHARMACEUTICALS : Provides Business Update and Reports 2016 Fourth Quart..
PU
2017Anthera Pharmaceuticals Provides Business Update and Reports 2016 Fourth Qua..
GL
2017ROBBINS ARROYO LLP : Anthera Pharmaceuticals, Inc. (ANTH) Misled Shareholders Ac..
BU
2017Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Anthera Pharmac..
PR
2017Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violatio..
BU
2016ANTHERA PHARMACEUTICALS : Announces the Phase 3 SOLUTION Study with Sollpura&tra..
PU
More news
News in other languages on ANTHERA PHARMACEUTICALS IN
2017ANTHERA PHARMACEUTICALS INC : REVERSE SPLIT: 1 of 8
2016Wall Street termine dans le rouge, le rally s'essouffle
2013ANTHERA PHARMACEUTICALS INC : REVERSE SPLIT: 1 of 8
More news
Analyst Recommendations on ANTHERA PHARMACEUTICALS IN
More recommendations
Sector news : Bio Therapeutic Drugs
02/18Sanofi to Work on Coronavirus Vaccine
DJ
02/18Gilead's Coronavirus Drug Trial Slowed Due to Lack of Eligible Recruits
DJ
02/12Coronavirus-Drug Development Becomes a Top Focus at Gilead
DJ
02/12GILEAD SCIENCES : Correction to Report About Gilead Sciences' Work on a Coronavi..
DJ
02/12Gilead Sciences Scrambles to Supply Experimental Coronavirus Drug
DJ
More sector news : Bio Therapeutic Drugs
Technical analysis trends ANTHERA PHARMACEUTICALS IN
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Managers
NameTitle
Paul F. Truex Chairman
May Liu CAO, Senior VP-Finance & Administration
David E. Thompson Independent Director
Christopher S. Henney Independent Director
Philip T. Sager Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ANTHERA PHARMACEUTICALS INC1
GILEAD SCIENCES3.97%84 777
VERTEX PHARMACEUTICALS12.32%63 762
REGENERON PHARMACEUTICALS6.41%43 287
WUXI APPTEC CO., LTD.23.75%26 550
GENMAB10.23%15 693